Company Filing History:
Years Active: 2013
Title: Praveen Rajendran: Innovator in Histone Deacetylase Inhibitors
Introduction
Praveen Rajendran is a notable inventor based in Corvallis, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target histone deacetylases (HDACs). His work is crucial for advancing therapeutic options for various diseases.
Latest Patents
Rajendran holds a patent for novel stilbene-like compounds that inhibit HDACs. The patent describes compounds of the general formula (I), along with their derivatives, analogs, and other forms. These compounds are designed to serve as therapeutic agents for diseases related to cellular growth, including malignant tumors, autoimmune diseases, skin diseases, infections, and inflammation.
Career Highlights
Praveen Rajendran is associated with Orchid Chemicals & Pharmaceuticals Limited, where he applies his expertise in drug development. His innovative approach has led to advancements in the pharmaceutical industry, particularly in the area of cancer treatment and other serious health conditions.
Collaborations
Rajendran collaborates with esteemed colleagues such as Sridharan Rajagopal and Virendra Kachhadia. Their combined efforts contribute to the ongoing research and development of effective pharmaceutical solutions.
Conclusion
Praveen Rajendran's work in developing histone deacetylase inhibitors showcases his commitment to improving healthcare through innovation. His contributions are vital for addressing complex diseases and enhancing therapeutic strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.